加载中........
×

2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

2012-4-24 我要评论0
Tags:   AAN  头痛  偏头痛  
分享到:

指南名称:2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

英文标题:Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

发布机构:美国神经病学学会(AAN,American Academy of Neurology)

发布日期:2012-4-24

简要介绍:OBJECTIVE: To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: What pharmacologic therapies are proven effective for migraine prevention?METHODS: The authors analyzed published studies from June 1999 to May 2009 using a structured review process to classify the evidence relative to the efficacy of various medications available in the United States for migraine prevention.Results and Recommendations: The author panel reviewed 284 abstracts, which ultimately yielded 29 Class I or Class II articles that are reviewed herein. Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective for migraine prevention and should be offered to patients with migraine to reduce migraine attack frequency and severity (Level A). Frovatriptan is effective for prevention of menstrual migraine (Level A). Lamotrigine is ineffective for migraine prevention (Level A).

来源:Neurology. 2012 Apr 24;78(17):1337-45.

下载地址:下载   (需要扣积分分, 梅斯医学APP免积分下载)
小提示:78%用户已下载梅斯医学APP,更方便阅读和交流,请扫描二维码直接下载APP

分享到:

(来自:梅斯医学APP)

回复

web对话